Picture Kentro Design Is Key to Your Success Berlin 650x100px

News > All

Total search results: 10149 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 95 96 97 ... 100 101 102  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Galapagos N.V.. (4/18/17). "Press Release: Galapagos Raises $338 Million Gross Proceeds in a U.S. Public Offering". Mechelen. 2017-04-18
Cobra Biologics Ltd.. (4/18/17). "Press Release: Cobra Biologics Embarks On £15m (165m SEK) Gene Therapy Manufacturing Operations Expansion". Keele & Matfors & Södertälje. 2017-04-18
Thermo Fisher Scientific Inc.. (4/18/17). "Press Release: Thermo Fisher Scientific Establishes Institute of Pathology at University Hospital Basel as Center of Excellence Partner". Carlsbad, CA. 2017-04-18
Roche. (4/17/17). "Press Release: Roche Announces Positive Interim Results for Emicizumab in Phase III Study of Children with Haemophilia A". Basel. 2017-04-17
Galapagos N.V.. (4/17/17). "Press Release: Galapagos Announces Launch of Proposed Public Offering". Mechelen. 2017-04-17
CRISPR Therapeutics AG. (4/17/17). "Press Release: CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with StrideBio". Basel, et al.. 2017-04-17
AMETEK, Inc.. (4/17/17). "Press Release: AMETEK to Acquire MOCON, Inc.". Berwyn, PA & Minneapolis, MN. 2017-04-17
Biotechpharma UAB. (4/14/17). "Press Release: Biotechpharma Further Expands GMP Manufacturing Capacity". Vilnius. 2017-04-14
Argen-X N.V. (Argenx). (4/13/17). "Press Release: Argenx Receives First Preclinical Milestone Payment in AbbVie Collaboration". Breda & Ghent. 2017-04-13
Bristol-Myers Squibb Company. (4/13/17). "Press Release: Bristol-Myers Squibb Enters into Separate Agreements with Biogen and Roche to License Anti-eTau and Anti-Myostatin Compounds, Respectively". New York, NY. 2017-04-13
CRISPR Therapeutics AG. (4/13/17). "Press Release: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision". Basel, et al.. 2017-04-13
Biotest AG. (4/13/17). "Press Release: Biotest Informs about Limited Availability of Albumin". Dreieich. 2017-04-13
Erytech Pharma. (4/13/17). "Press Release: Erytech to Raise €70.5 Million in a Private Placement to U.S. and European Investors [Not for United States, Australia, Canada or Japan]". 2017-04-13
GlucoMe Ltd.. (4/13/17). "Press Release: GlucoMe Appoints John Erickson as EVP, General Manager North America". Tel Aviv. 2017-04-13
HiberGene Diagnostics Ltd.. (4/12/17). "Press Release: HiberGene Closes €6.7m Series B Funding Round". Dublin. 2017-04-12
Polyphor Ltd.. (4/12/17). "Press Release: Polyphor Announces Closing of CHF 40 Million Private Financing Round". Allschwil. 2017-04-12
Wilex AG. (4/12/17). "Press Release: Interim Management Statement on the First Three Months of 2017". Munich. 2017-04-12
Transgene S.A.. (4/12/17). "Press Release: Transgene and Institut Bergonié Start the Phase 2 Part of the METROmaJX Trial". Strasbourg. 2017-04-12
Endo International plc. (4/12/17). "Press Release: Endo International plc Announces Pricing of Private Offering of Senior Secured Notes". Dublin. 2017-04-12
Argen-X N.V. (Argenx). (4/12/17). "Press Release: Argenx Launches Phase II Study of ARGX-110 as a Monotherapy in Relapsed/Refractory CTCL Patients". Breda & Ghent. 2017-04-12
Cellectis S.A.. (4/12/17). "Press Release: Cellectis S.A. to Explore Possible Initial Public Offering of Calyxt, Inc.". 2017-04-12
Agendia Inc.. (4/12/17). "Press Release: Agendia Appoints Patrick J. Balthrop Sr., Former CEO of Luminex, as Chairman". Irvine, CA & Amsterdam. 2017-04-12
Erytech Pharma. (4/12/17). "Press Release: Erytech Launches Capital Increase by Means of a Private Placement [Not for United States, Australia, Canada or Japan]". 2017-04-12
Intellia Therapeutics, Inc.. (4/11/17). "Press Release: Intellia Therapeutics Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing Technology Patent". Cambridge, MA. 2017-04-11
MorphoSys AG. (4/11/17). "Press Release: MorphoSys to Present at Upcoming Conferences". Planegg-Martinsried. 2017-04-11
Apogenix AG. (4/11/17). "Press Release: Apogenix Announces Initiation of Clinical Development for ABBV-621 to Treat Solid and Hematologic Tumors by Partner AbbVie". Heidelberg. 2017-04-11
Sygnis AG. (4/11/17). "Press Release: Sygnis AG Successfully Completes Integration of Recently Acquired C.B.S. Scientific". Madrid & Heidelberg. 2017-04-11
Optibrium Ltd.. (4/11/17). "Press Release: Lhasa and Optibrium Enter Research and Product Development Collaboration". Cambridge & Leeds. 2017-04-11
Themis Bioscience GmbH. (4/11/17). "Press Release: Zika Virus – Themis Bioscience Initiates Worldwide First Study With Live Attenuated Recombinant Vaccine". Vienna. 2017-04-11
Lead Discovery Center GmbH. (4/11/17). "Press Release: LDC and SOTIO Enter License and Collaboration Agreement for Cancer Metabolism Program". Dortmund & Praque. 2017-04-11
Genome Diagnostics B.V. (GenDx). (4/10/17). "Press Release: GenDx Signs Global Reseller Agreement for Thermo Fisher Scientific Next-Generation Sequencing Instruments". Utrecht. 2017-04-10
Consilium Strategic Communications Ltd.. (4/10/17). "Press Release: Consilium Strategic Communications and Westwicke Partners Enter into Joint Venture for Healthcare Focused US IR Advisory". London & Baltimore, MD. 2017-04-10
Adaptimmune Therapeutics plc. (4/10/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering". Philadeliphia, PA & Oxford. 2017-04-10
Roche. (4/10/17). "Press Release: Phase III Study Shows Roche’s Alecensa Was Superior to Crizotinib in a Specific Type of Lung Cancer". Basel. 2017-04-10
Transgene S.A.. (4/10/17). "Press Release: Transgene Announces Upcoming Investor Meetings and R&D Day". Strasbourg. 2017-04-10
Endo International plc. (4/10/17). "Press Release: Endo International plc Announces Proposed Private Offering of Senior Secured Notes". Dublin. 2017-04-10
Illumina, Inc.. (4/10/17). "Press Release: Illumina Launches the VeriSeq NIPT Solution in Europe". San Diego, CA. 2017-04-10
Indivumed GmbH. (4/7/17). "Press Release: Indivumed Celebrates 15 Years of Successful Construction of the World's Leading Cancer Database". Hamburg. 2017-04-07
Grünenthal GmbH. (4/7/17). "Press Release: The Grünenthal Group Today Announced the Acquisition of the Company Adhesys Medical to Expand Its Pipeline of Medical Devices for its Business with Surgeons". Aachen. 2017-04-07
GSK Stockmann. (4/7/17). "Pressemitteilung: GSK Stockmann berät beim Verkauf von Adhesys Medical an Grünenthal". 2017-04-07
Microsaic Systems plc. (4/7/17). "Press Release: Microsaic Signs Amended Agreement with Global Partner". 2017-04-07
Pirbright Institute, The. (4/7/17). "Press Release: Dr. Bryan Charleston Appointed as Director of The Pirbright Institute". 2017-04-07
Probiodrug AG. (4/7/17). "Press Release: Last Patient Last Visit (LPLV) Reached in the SAPHIR Study". Halle (Saale). 2017-04-07
Biotest AG. (4/7/17). "Press Release: Biotest AG and Creat Enter into Business Combination Agreement". Dreieich. 2017-04-07
MGB Biopharma Ltd.. (4/6/17). "Press Release: MGB Biopharma Closes $1 Million Financing Round to Finance Manufacturing of MGB-BP-3 for Phase II Study in Clostridium difficile-Associated Disease (CDAD)". Glasgow. 2017-04-06
Asceneuron S.A.. (4/6/17). "Press Release: Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor". Lausanne. 2017-04-06
Novartis AG. (4/6/17). "Press Release: Novartis to Strengthen R&D Pipeline by In-licensing ECF843 for Ophthalmic Indications". Basel. 2017-04-06
Labfolder GmbH. (4/6/17). "Press Release: The Berlin Institute of Health (BIH) Adopts the Digital Laboratory Data Management Platform from the Berlin-based Start-up Labfolder". Berlin. 2017-04-06
Nanobiotix S.A.. (4/6/17). "Press Release: Nanobiotix Launches Capital Increase by Means of an Accelerated Bookbuild Offering [Not for United States, Canada, Australia or Japan]". Paris & Cambridge, MA. 2017-04-06
Nanobiotix S.A.. (4/6/17). "Press Release: Nanobiotix Successfully Completes approx. EUR 25.1 Million Private Placement of New Shares [Not for United States, Canada, Australia or Japan]". Paris & Cambridge, MA. 2017-04-06
bioMérieux S.A.. (4/6/17). "Press Release: bioMérieux Receives FDA 510(k) Clearance for its BacT/Alert VIRTUO Fully Automated Blood Culture System". Marcy l’Étoile. 2017-04-06
Curetis N.V.. (4/6/17). "Press Release: Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing". Amsterdam & Holzgerlingen. 2017-04-06
Sartorius AG. (4/6/17). "Press Release: Resolutions of the Annual Shareholders’ Meeting of Sartorius AG". Göttingen. 2017-04-06
Novacyt S.A.. (4/6/17). "Press Release: Novacyt Announces Bond Issue". Paris & Cambridge. 2017-04-06
Adaptimmune Therapeutics plc. (4/5/17). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-04-05
Heptares Therapeutics Ltd.. (4/5/17). "Press Release: Heptares to Receive US$12 Million Milestone Payment from AstraZeneca". London. 2017-04-05
SkinBioTherapeutics plc. (4/5/17). "Press Release: First Day of Dealings. Company to Trade under Ticker Code SBTX [Not for US, AU, CA, JP, ZA, IE, et al.]". Manchester. 2017-04-05
Biosyntia ApS. (4/5/17). "Press Release: Biosyntia and FGen to Collaborate on Development of Vitamin Production Strain". Copenhagen & Basel. 2017-04-05
Roche. (4/5/17). "Press Release: Improving Consistency in the Diagnosis of Cervical Pre-cancers. Roche CINtec Histology Test Receives FDA Clearance". Basel. 2017-04-05
Evotec AG. (4/5/17). "Press Release: Evotec Achieves First Milestone in Diabetes Alliance with Sanofi". Hamburg. 2017-04-05
Oncgnostics GmbH. (4/5/17). "Press Release: GynTect Soon Available in China. Oncgnostics Grants Exclusive License for GynTect to the Chinese Sinopharm Subsidiary CJMT – Approval for the Chinese Market Planned". Jena. 2017-04-05
Topas Therapeutics GmbH. (4/4/17). "Press Release: Paul Sekhri Joins Topas Therapeutics as Chairman of the Board". Hamburg. 2017-04-04
Biocartis Group N.V.. (4/4/17). "Press Release: Biocartis Establishes US Subsidiary and Appoints US General Manager". Mechelen. 2017-04-04
Nanobiotix S.A.. (4/4/17). "Press Release: Nanobiotix Expands Its Clinical Development in Head and Neck Cancer and Immuno-oncology. New Clinical Data to Be Presented at ASCO". Paris & Cambridge, MA. 2017-04-04
MTIP MedTech Innovation Partners AG. (4/4/17). "Press Release: Finales Closing für ersten MTIP Fonds". Basel. 2017-04-04
Eurofins Scientific. (4/4/17). "Press Release: Eurofins Consolidates Its Market Leadership in Environment Testing in Finland with the Acquisition of Ahma Group". 2017-04-04
Numares AG. (4/4/17). "Press Release: Numares Announces Commercial Launch of renalTX-SCORE". Regensburg. 2017-04-04
Nightstar Therapeutics plc. (4/4/17). "Press Release: NightstaRx Appoints Healthcare Finance Leader Senthil Sundaram as Chief Financial Officer". Boston, MA. 2017-04-04
LGC Ltd.. (4/3/17). "Press Release: LGC Acquires Axolabs and Invests in GMP Manufacturing Capacity for Therapeutic Nucleic Acids". 2017-04-03
DSM N.V.. (4/3/17). "Press Release: DSM Opens New Biotechnology Center in Delft, the Netherlands". Delft. 2017-04-03
Ogeda S.A.. (4/3/17). "Press Release: Astellas to Acquire Ogeda SA". Tokyo & Gosselies. 2017-04-03
Sartorius AG. (4/3/17). "Press Release: Sartorius Acquires Software Company Umetrics and Closes the Acquisition of Essen BioScience". Göttingen. 2017-04-03
Novartis AG. (4/3/17). "Press Release: Novartis Drug Combination Tafinlar + Mekinist Receives EU Approval for BRAF V600-positive Advanced Non-small Cell Lung Cancer (NSCLC)". Basel. 2017-04-03
Menarini Silicon Biosystems, Inc.. (4/3/17). "Press Release: Menarini-Silicon Biosystems Completes Acquisition of CellSearch Assets". Bologna & Philadelphia, PA. 2017-04-03
Eurofins Scientific. (4/3/17). "Press Release: Eurofins Secures Environment Testing Market Leadership in Finland with the Acquisition of the Laboratory Business of Ramboll Group". 2017-04-03
Roche. (4/3/17). "Press Release: Phase III ALUR Study Supports the Use of Roche’s Alecensa for People with Advanced ALK-positive Lung Cancer". Basel. 2017-04-03
Roche. (4/3/17). "Press Release: Roche Launches cobas Liat PCR System with Four Assays into CE-Markets". Basel. 2017-04-03
Probiodrug AG. (4/3/17). "Press Release: Probiodrug to Attend International Conferences in April 2017". Halle (Saale). 2017-04-03
MorphoSys AG. (4/3/17). "Press Release: MorphoSys Nominates New Candidate for Supervisory Board". Planegg-Martinsried. 2017-04-03
Bicycle Therapeutics Ltd.. (4/3/17). "Press Release: Bicycle Therapeutics Announces Presentations at the 2017 American Association for Cancer Research Annual Meeting". Cambridge, MA & Cambridge. 2017-04-03
Advion, Inc.. (4/3/17). "Press Release: Advion’s New Inert Probe Allows Real Time Reaction Monitoring of Air Sensitive Compounds". Ithaca, NY. 2017-04-03
Cellnovo. (4/3/17). "Press Release: Cellnovo Appoints Erwan Martin as Chief Financial Officer". Paris. 2017-04-03
MLM Medical Labs GmbH. (4/2/17). "Press Release: MLM Welcomes Annette Angenendt as New Marketing Manager". 2017-04-02
AB Science S.A.. (3/31/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-31
Calypso Biotech S.A.. (3/31/17). "Press Release: Calypso Biotech Licenses CALY-001 Best-in-Class Anti-MMP-9 Antibody to EA Pharma". Geneva. 2017-03-31
Qiagen N.V.. (3/31/17). "Press Release: Qiagen Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer". Hilden & Germantown, MD. 2017-03-31
Indivumed GmbH. (3/31/17). "Press Release: Indivumed Founder and CEO Recognized for Contribution to Liquid Biopsy Innovation". Hamburg. 2017-03-31
Oryzon Genomics S.A.. (3/31/17). "Press Release: Oryzon Raises €18 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA, et al.]". Barcelona. 2017-03-31
AstraZeneca plc. (3/31/17). "Press Release: Tagrisso (osimertinib) Receives US FDA Full Approval". 2017-03-31
MeiraGTx Holdings plc. (3/31/17). "Press Release: MeiraGTx Announces Opening of European Technology Hub". Leiden. 2017-03-31
Oxford University Innovation. (3/31/17). "Press Release: Biochemical Superglue Bonds with SpyBiotech’s Vision of Next-generation Vaccines". 2017-03-31
Oxford Biomedica plc. (3/30/17). "Press Release: Oxford BioMedica Notes Acceptance by FDA of a Biologics License Application (BLA) Filing for CTL019". Oxford. 2017-03-30
Neovacs S.A.. (3/30/17). "Press Release: Neovacs Provides Corporate Update and Reports Full Year 2016 Financial Results". Paris. 2017-03-30
Genomics Medicine Ireland Ltd.. (3/30/17). "Press Release: Genomics Medicine Ireland Announces Two Appointments to Its Board. Dr. Kari Stefánsson and Dr. Paul Saunders Appointed to the Board". Dublin. 2017-03-30
Probiodrug AG. (3/30/17). "Press Release: Probiodrug Reports Full Year 2016 Financial Results". Halle (Saale). 2017-03-30
Qiagen N.V.. (3/30/17). "Press Release: Qiagen Joins CANCER-ID Consortium for Liquid Biopsy Workflows". Hilden & Germantown, MD. 2017-03-30
Symetis AG. (3/30/17). "Press Release: Symetis and Boston Scientific Reach USD 435 Million Purchase Agreement". Ecublens. 2017-03-30
Boston Scientific Corporation. (3/30/17). "Press Release: Boston Scientific Announces Agreement to Acquire Symetis". Marlborough, MA. 2017-03-30
CRISPR Therapeutics AG. (3/30/17). "Press Release: CRISPR Therapeutics to Present at the 16th Annual Needham Healthcare Conference". Basel & Cambridge, MA. 2017-03-30
CARB-X. (3/30/17). "Press Release: CARB-X Injects up to $48 Million to Accelerate First Powered by CARB-X Portfolio of Drug Discovery and Development Projects to Tackle Antibiotic Resistance". Washington, DC & London. 2017-03-30
next pagenext page 1 2 3 ... 95 96 97 ... 100 101 102  next pagenext page


Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top